Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register

Supplying Medicines and Supplements to Côte d'Ivoire

A practical guide for Ivorian importers, wholesalers and hospital buyers who source from abroad, and for manufacturers and exporters worldwide selling into Côte d'Ivoire.

This page in other languages: English · Français

Côte d'Ivoire imports over 90% of its medicines, in a market worth around €537 million. Its regulator, AIRP, set up in 2017, is preparing for WHO benchmarking at maturity level 3 and has issued a string of new decisions since 2024, including formal reliance rules.

Registration follows the rules of the West African Economic and Monetary Union (UEMOA), which its French-speaking neighbours share.

Côte d'Ivoire at a glance

RegulatorAutorité Ivoirienne de Régulation Pharmaceutique (AIRP), created in 2017
RegistrationA CTD dossier under UEMOA Regulation 04/2020, with full, abridged and priority routes. Module 1 must be in French
RelianceA priority route for WHO-prequalified and stringent-authority-approved products, formal reliance decisions in 2024 and 2025, and the ECOWAS joint assessment
Public buyerNouvelle Pharmacie de la Santé Publique (NPSP), which supplies public health facilities
PricingPrices approved by AIRP, with set multipliers on the wholesale price for imported and local products

How to supply medicines to Côte d'Ivoire

  1. Decide who applies. The manufacturer or licence holder applies, or a local representative with a power of attorney. Most products reach the market through local representation agencies.
  2. Prepare the dossier. A CTD dossier, with Module 1 in French, a CoPP and the plant's GMP evidence.
  3. Choose the route. Full, abridged or priority review, or the ECOWAS joint assessment if you also want other West African markets.
  4. Supply. Only AIRP-licensed establishments can import, and every import needs AIRP's authorisation. Private supply runs through a few wholesalers to about 2,000 pharmacies; public supply goes through NPSP.

A special import authorisation (ASI) covers unregistered products, and a March 2026 AIRP decision set emergency rules for unapproved products. See named-patient and special import and government tender supply.

Supplements

Food supplements fall under AIRP, which ran a declaration campaign for health products in 2024 and 2025. Health claims in advertising need AIRP's prior approval. We help brands get supplements made under their own label by GMP-certified contract manufacturers: see nutraceutical private label.

What people in Côte d'Ivoire search for

Semrush does not cover Côte d'Ivoire, but Google Keyword Planner shows buyers there searching in French: “compléments alimentaires”, “vitamine C”, “vitamine D”, “vitamine B12” and “acide folique” each get between 1,000 and 10,000 searches a month. Medicines are typed by their French generic name in the same range, such as “amoxicilline”, “azithromycine”, “ceftriaxone” and “ciprofloxacine”. The market itself is import-led, with over 90% of medicines imported.

How importers and distributors in Côte d'Ivoire search

Trade phrases such as “grossiste pharmaceutique”, “distributeur de médicaments”, “fournisseur de médicaments” and “autorisation de mise sur le marché” register only weakly in Keyword Planner, at 10 to 100 searches a month.

Originator brands also searched by name include Augmentin (amoxicillin and clavulanic acid), Coartem (artemether and lumefantrine), Doliprane (paracetamol), Flagyl (metronidazole), Ozempic (semaglutide) and Spasfon (phloroglucinol). Brand names are trademarks of their owners and are used only to identify the medicine.

Supplements we can help you make

Medicines widely bought in Côte d'Ivoire include antimalarials, antibiotics and treatments for chronic diseases. Some examples we list:

Documents to ask your supplier for

Not sure a supplier is genuine? Read how to verify a pharmaceutical supplier. For the neighbouring markets, see our Sub-Saharan Africa import guide.

Sourcing for Côte d'Ivoire?

Send the product, strength, quantity and the documents your regulator needs. We will match you with GMP-certified manufacturers and suppliers who can serve your market, wherever they are based.

Send your requirement Talk to our team

Frequently asked questions

The Autorité Ivoirienne de Régulation Pharmaceutique (AIRP), created in 2017.

The UEMOA rules (Regulation 04/2020), with a CTD dossier. Module 1 must be in French.

Yes. AIRP has a priority route for WHO-prequalified and stringent-authority-approved products, formal reliance decisions from 2024 and 2025, and takes part in the ECOWAS joint assessment.

Only establishments licensed by AIRP, and every import needs AIRP's authorisation.

Yes, with a special import authorisation (ASI). A March 2026 AIRP decision also set emergency rules for unapproved products.

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us